Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000155403 | SCV000205090 | benign | not specified | 2012-05-07 | criteria provided, single submitter | clinical testing | Val2820Ile in Exon 42 of USH2A: This variant is not expected to have clinical si gnificance because it has been identified in 1.4% (54/3738) of African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http: //evs.gs.washington.edu/EVS; dbSNP rs59174500). |
Gene |
RCV000965590 | SCV000523724 | benign | not provided | 2019-05-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000965590 | SCV001112860 | benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002492586 | SCV002799465 | likely benign | Usher syndrome type 2A; Retinitis pigmentosa 39 | 2022-05-20 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003453175 | SCV004182803 | likely benign | Retinitis pigmentosa 39 | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001826838 | SCV004182804 | likely benign | Usher syndrome type 2A | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000965590 | SCV005287654 | benign | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV001826838 | SCV002090820 | benign | Usher syndrome type 2A | 2019-12-08 | no assertion criteria provided | clinical testing |